Joshua M. Eizen, See Remarks at AN2 Therapeutics, Inc. (ANTX), sold 24,854 shares at $1.01 ($25K) on 2026-01-06, disclosed to the SEC on 2026-01-07.
Open-market sale of $25k ANTX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.00 | 17,923 | $18K | 71.9% |
| 2 | $1.01 | 6,931 | $7K | 28.1% |
| Total | $1.00 avg | 24,854 | $25K | 100% |
| Filing → |
| ANTX | SELL | 2025-01-07 | $13K | — | Filing → |